Based at Plymouth’s International Medical and Technology Park alongside partners at UHPNT, the laboratory is the heart of Biovault’s facility. Stem cell scientists, quality managers and customer advisors collaborate here to provide an informed and dependable service.
Biovault have led the way in human tissue processing and storage since 2004. They have released over 4,000 stem cell units derived from peripheral blood, bone marrow and cord blood for transplantation and their unrivalled facilities and expertise allow them to work closely with public and private clinics and hospitals around the world. Biovault Family offers parents the chance to save their baby’s umbilical cord stem cells to help safeguard their child’s future health. They have successfully collected and processed cord blood and tissue from over 30 different countries and have released cord blood stem cells to treat conditions ranging from leukaemia and neuroblastoma to sickle cell disease and cerebral palsy.Biovault are curious and innovative pioneers in stem cell technology. As a centre for stem cell research and development, their state-of-the-art laboratories and long-standing relationships with the University of Plymouth support their scientists to develop an understanding of human stem cells and how they might be used therapeutically. All at Biovault believe this is only the beginning for regenerative medicine and intend to play a positive role in its future.